Deng F, Tuomi SK, Neuvonen M, Hirvensalo P, Kulju S, Wenzel C, et al. Comparative hepatic and Intestinal Efflux Transport of Statins. Drug Metab Dispos. 2021;49:750–9.

Article  CAS  PubMed  Google Scholar 

Keskitalo JE, Zolk O, Fromm MF, Kurkinen KJ, Neuvonen PJ, Niemi M. ABCG2 polymorphism markedly affects the pharmacokinetics of atorvastatin and rosuvastatin. Clin Pharmacol Ther. 2009;86:197–203.

Article  CAS  PubMed  Google Scholar 

Doyle LA, Yang W, Abruzzo LV, Krogmann T, Gao Y, Rishi AK, et al. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci U S A. 1998;95:15665–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Morisaki K, Robey RW, Ozvegy-Laczka C, Honjo Y, Polgar O, Steadman K, et al. Single nucleotide polymorphisms modify the transporter activity of ABCG2. Cancer Chemother Pharmacol. 2005;56:161–72.

Article  CAS  PubMed  Google Scholar 

Kasza I, Várady G, Andrikovics H, Koszarska M, Tordai A, Scheffer GL, et al. Expression levels of the ABCG2 multidrug transporter in human erythrocytes correspond to pharmacologically relevant genetic variations. PLoS ONE. 2012;7:e48423.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Taylor NMI, Manolaridis I, Jackson SM, Kowal J, Stahlberg H, Locher KP. Structure of the human multidrug transporter ABCG2. Nature. 2017;546:504–9.

Article  CAS  PubMed  Google Scholar 

Jackson SM, Manolaridis I, Kowal J, Zechner M, Taylor NMI, Bause M, et al. Structural basis of small-molecule inhibition of human multidrug transporter ABCG2. Nat Struct Mol Biol. 2018;25(4):333–40.

Article  CAS  PubMed  Google Scholar 

Scharenberg CW, Harkey MA, Torok-Storb B. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood. 2002;99:507–12.

Article  CAS  PubMed  Google Scholar 

Scharenberg C, Mannowetz N, Robey RW, Brendel C, Repges P, Sahrhage T, et al. ABCG2 is expressed in late spermatogenesis and is associated with the acrosome. Biochem Biophys Res Commun. 2009;378:302–7.

Article  CAS  PubMed  Google Scholar 

Szilagyi JT, Vetrano AM, Laskin JD, Aleksunes LM. Localization of the placental BCRP/ABCG2 transporter to lipid rafts: role for cholesterol in mediating efflux activity. Placenta. 2017;55:29–36.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kobayashi D, Ieiri I, Hirota T, Takane H, Maegawa S, Kigawa J, et al. Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta. Drug Metab Dispos. 2005;33:94–101.

Article  CAS  PubMed  Google Scholar 

Pollex EK, Anger G, Hutson J, Koren G, Piquette-Miller M. Breast cancer resistance protein (BCRP)-mediated glyburide transport: effect of the C421A/Q141K BCRP single-nucleotide polymorphism. Drug Metab Dispos. 2010;38:740–4.

Article  CAS  PubMed  Google Scholar 

Yanase K, Tsukahara S, Mitsuhashi J, Sugimoto Y. Functional SNPs of the breast cancer resistance protein-therapeutic effects and inhibitor development. Cancer Lett. 2006;234:73–80.

Article  CAS  PubMed  Google Scholar 

Keskitalo JE, Pasanen MK, Neuvonen PJ, Niemi M. Different effects of the ABCG2 c.421C > A SNP on the pharmacokinetics of fluvastatin, pravastatin and simvastatin. Pharmacogenomics. 2009;10:1617–24.

Article  CAS  PubMed  Google Scholar 

Song Y, Lim HH, Yee J, Yoon HY, Gwak HS. The Association between ABCG2 421C > A (rs2231142) polymorphism and Rosuvastatin Pharmacokinetics: a systematic review and Meta-analysis. Pharmaceutics. 2022;14:501.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu M, To KK, Mak VW, Tomlinson B. The ABCG2 transporter and its relations with the pharmacokinetics, drug interaction and lipid-lowering effects of statins. Expert Opin Drug Metab Toxicol. 2011;7:49–62.

Article  CAS  PubMed  Google Scholar 

Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.

Article  PubMed  PubMed Central  Google Scholar 

DerSimonian R, Kacker R. Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials. 2007;28:105–14.

Article  PubMed  Google Scholar 

Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–101.

Article  CAS  PubMed  Google Scholar 

Hegedüs C, Telbisz Á, Hegedűs T, Sarkadi B, Özvegy-Laczka C. Lipid regulation of the ABCB1 and ABCG2 multidrug transporters. Adv Cancer Res. 2015;125:97–137.

Article  PubMed  Google Scholar 

Zhang W, Yu BN, He YJ, Fan L, Li Q, Liu ZQ, et al. Role of BCRP 421C > A polymorphism on rosuvastatin pharmacokinetics in healthy Chinese males. Clin Chim Acta. 2006;373:99–103.

Article  CAS  PubMed  Google Scholar 

Lu Z, Luo Z, Jia A, Yu L, Muhammad I, Zeng W, et al. Associations of the ABCA1 gene polymorphisms with plasma lipid levels: a meta-analysis. Med (Baltim). 2018;97:e13521.

Article  CAS  Google Scholar 

Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937–52.

Article  PubMed  Google Scholar 

Kononov S, Mal G, Azarova I, Klyosova E, Bykanova M, Churnosov M, et al. Pharmacogenetic loci for rosuvastatin are associated with intima-media thickness change and coronary artery disease risk. Pharmacogenomics. 2022;23:15–34.

Article  CAS  PubMed  Google Scholar 

Shek AB, Kurbanov RD, Abdullaeva GJ, Nagay AV, Hoshimov SU, Nizamov UI, et al. Simvastatin intolerance genetic determinants: some features in ethnic Uzbek patients with coronary artery disease. Arch Med Sci Atheroscler Dis. 2017;2:e68–e75.

Article  PubMed  PubMed Central  Google Scholar 

Luke MM, Kane JP, Liu DM, Rowland CM, Shiffman D, Cassano J, et al. A polymorphism in the protease-like domain of apolipoprotein(a) is associated with severe coronary artery disease. Arterioscler Thromb Vasc Biol. 2007;27:2030–6.

Article  CAS  PubMed  Google Scholar 

Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA et al. /ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139:e1082-e143.

Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41:111–88.

Article  PubMed  Google Scholar 

Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143–421.

Article  Google Scholar 

Dehghan A, Köttgen A, Yang Q, Hwang SJ, Kao WL, Rivadeneira F, et al. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet. 2008;372:1953–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li X, Meng X, He Y, Spiliopoulou A, Timofeeva M, Wei WQ, et al. Genetically determined serum urate levels and cardiovascular and other diseases in UK Biobank cohort: a phenome-wide mendelian randomization study. PLoS Med. 2019;16:e1002937.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chasman DI, Giulianini F, MacFadyen J, Barratt BJ, Nyberg F, Ridker PM. Genetic determinants of statin-induced low-density lipoprotein cholesterol reduction: the justification for the Use of statins in Prevention: an intervention trial evaluating Rosuvastatin (JUPITER) trial. Circ Cardiovasc Genet. 2012;5:257–64.

Article  CAS  PubMed  Google Scholar 

Chu AY, Guilianini F, Barratt BJ, Nyberg F, Chasman DI, Ridker PM. Pharmacogenetic determinants of statin-induced reductions in C-reactive protein. Circ Cardiovasc Genet. 2012;5:58–65.

Article  CAS  PubMed  Google Scholar 

Lehtisalo M, Taskinen S, Tarkiainen EK, Neuvonen M, Viinamäki J, Paile-Hyvärinen M, et al. A comprehensive pharmacogenomic study indicates roles for SLCO1B1, ABCG2 and SLCO2B1 in rosuvastatin pharmacokinetics. Br J Clin Pharmacol. 2023;89:242–52.

Article  CAS  PubMed  Google Scholar